John O'Loughlin > Weil, Gotshal & Manges LLP > Washington DC, United States > Lawyer Profile
Weil, Gotshal & Manges LLP Offices
2001 M STREET, NW, SUITE 600
WASHINGTON, DC 20036
DISTRICT OF COLUMBIA
United States
- Firm Profile
- Go to...
John O'Loughlin
Position
Partner
Career
John O’Loughlin is a partner in Weil’s Corporate Department. John’s practice encompasses a wide range of administrative and regulatory compliance matters, with a particular focus on product stewardship and compliance with health and safety regulations. He advises clients in matters under the jurisdiction of the Environmental Protection Agency, the Food and Drug Administration, the Consumer Product Safety Commission, the Occupational Safety and Health Administration, and the Nuclear Regulatory Commission. He also counsels clients on compliance matters involving sensitive products and services in cross-border transactions. He has worked on numerous mergers, acquisitions and other transactions over the past two and a half decades, advising financial institutions, strategic buyers and sellers, private equity funds, pension funds, sovereign wealth funds and other investors. He has experience working with both lenders and borrowers on debt financings, underwriters and issuers on equity offerings, and investors and managers in the fund formation context.
Education
University of Maryland School of Law (J.D., 1996); Boston University (M.A., 1985); Towson University (B.S., 1983).
Top Tier Firm Rankings
- Finance > Capital markets: debt offerings
- M&A/corporate and commercial > Corporate governance
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Dispute resolution > General commercial disputes
- Tax > International tax
- Dispute resolution > Leading trial lawyers
- Dispute resolution > Leading trial lawyers
- Dispute resolution > M&A litigation: defense
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Antitrust > Merger control
- Intellectual property > Patents: licensing
- Finance > Restructuring (including bankruptcy): corporate
- Media, technology and telecoms > Technology transactions
- Tax > US taxes: non-contentious
Firm Rankings
- Media, technology and telecoms > Advertising and marketing: litigation
- Finance > Capital markets: equity offerings
- Intellectual property > Copyright
- Tax > Financial products
- Media, technology and telecoms > Media and entertainment: litigation
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Industry focus > Sport
- Finance > Structured finance: securitization
- Intellectual property > Trade secrets (litigation and non-contentious matters)
- Labor and employment > Workplace and employment counseling
- Finance > Capital markets: high-yield debt offerings
- Antitrust > Civil litigation/class actions: defense
- Energy > Energy transactions: oil and gas
- Labor and employment > Labor and employment disputes (including collective actions)
- Healthcare > Life sciences
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate
- Real estate > Real estate investment trusts (REITs)
- Media, technology and telecoms > Telecoms and broadcast: transactions
- Intellectual property > Trademarks: litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense